Amanda Blackford
Amanda Blackford
Principal Biostatistician, Johns Hopkins University
Verified email at
Cited by
Cited by
Egr-2 and Egr-3 are negative regulators of T cell activation
M Safford, S Collins, MA Lutz, A Allen, CT Huang, J Kowalski, A Blackford, ...
Nature immunology 6 (5), 472-480, 2005
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
M Sausen, RJ Leary, S Jones, J Wu, CP Reynolds, X Liu, A Blackford, ...
Nature genetics 45 (1), 12-17, 2013
RNAi-mediated silencing of nuclear factor erythroid-2–related factor 2 gene expression in non–small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy
A Singh, S Boldin-Adamsky, RK Thimmulappa, SK Rath, H Ashush, ...
Cancer research 68 (19), 7975-7984, 2008
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer
A Blackford, OK Serrano, CL Wolfgang, G Parmigiani, S Jones, X Zhang, ...
Clinical cancer research 15 (14), 4674-4679, 2009
A combination of molecular markers and clinical features improve the classification of pancreatic cysts
S Springer, Y Wang, M Dal Molin, DL Masica, Y Jiao, I Kinde, A Blackford, ...
Gastroenterology 149 (6), 1501-1510, 2015
Common variation at 2p13. 3, 3q29, 7p13 and 17q25. 1 associated with susceptibility to pancreatic cancer
EJ Childs, E Mocci, D Campa, PM Bracci, S Gallinger, M Goggins, D Li, ...
Nature genetics 47 (8), 911-916, 2015
18F-DCFBC PET/CT for PSMA-based detection and characterization of primary prostate cancer
SP Rowe, KL Gage, SF Faraj, KJ Macura, TC Cornish, ...
Journal of Nuclear Medicine 56 (7), 1003-1010, 2015
Genetic mutations associated with cigarette smoking in pancreatic cancer
A Blackford, G Parmigiani, TW Kensler, C Wolfgang, S Jones, X Zhang, ...
Cancer research 69 (8), 3681-3688, 2009
Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002
CF Snyder, KD Frick, ME Kantsiper, KS Peairs, RJ Herbert, AL Blackford, ...
Journal of Clinical Oncology 27 (7), 1054, 2009
Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas
M Dal Molin, H Matthaei, J Wu, A Blackford, M Debeljak, N Rezaee, ...
Annals of surgical oncology 20 (12), 3802-3808, 2013
PSMA-based [18 F] DCFPyL PET/CT is superior to conventional imaging for lesion detection in patients with metastatic prostate cancer
SP Rowe, KJ Macura, E Mena, AL Blackford, R Nadal, ES Antonarakis, ...
Molecular imaging and biology 18 (3), 411-419, 2016
Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer
ES Antonarakis, EI Heath, DC Smith, D Rathkopf, AL Blackford, DC Danila, ...
The oncologist 18 (2), 163, 2013
Preventive care for colorectal cancer survivors: a 5-year longitudinal study
CF Snyder, CC Earle, RJ Herbert, BA Neville, AL Blackford, KD Frick
Journal of Clinical Oncology 26 (7), 1073-1079, 2008
Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study
CF Snyder, KD Frick, KS Peairs, ME Kantsiper, RJ Herbert, AL Blackford, ...
Journal of general internal medicine 24 (4), 469-474, 2009
Prediction of response to immune checkpoint inhibitor therapy using early-time-point 18F-FDG PET/CT imaging in patients with advanced melanoma
SY Cho, EJ Lipson, HJ Im, SP Rowe, EM Gonzalez, A Blackford, ...
Journal of Nuclear Medicine 58 (9), 1421-1428, 2017
Trends in follow-up and preventive care for colorectal cancer survivors
CF Snyder, CC Earle, RJ Herbert, BA Neville, AL Blackford, KD Frick
Journal of general internal medicine 23 (3), 254-259, 2008
Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance
MI Canto, JA Almario, RD Schulick, CJ Yeo, A Klein, A Blackford, EJ Shin, ...
Gastroenterology 155 (3), 740-751. e2, 2018
The role of stereotactic body radiation therapy for pancreatic cancer: a single-institution experience
S Moningi, AS Dholakia, SP Raman, A Blackford, JL Cameron, DT Le, ...
Annals of surgical oncology 22 (7), 2352-2358, 2015
Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages
J Yu, AL Blackford, M Dal Molin, CL Wolfgang, M Goggins
Gut 64 (11), 1783-1789, 2015
The importance of IGHV mutational status in del (11q) and del (17p) chronic lymphocytic leukemia
DE Gladstone, A Blackford, E Cho, L Swinnen, Y Kasamon, CD Gocke, ...
Clinical Lymphoma Myeloma and Leukemia 12 (2), 132-137, 2012
The system can't perform the operation now. Try again later.
Articles 1–20